발행물

전체 논문

402

201

Duloxetine: a new psychopharmacologic treatment option for fibromyalgia?
배치운, masand
Current Psychiatry Reports, 200806

202

An open-label, rater-blinded, flexible-dose, 8-week trial of escitalopram in patients with major depressive disorder with atypical features.
배치운, Masand PS, Peindl K, Mannelli P, Han C, Marks DM, Patkar AA
Primary Care Companion to the Journal of Clinical Psychiatry, 200806

203

History of depressive and anxiety disorders and paroxetine response in patients with irritable bowel syndrome: post hoc analysis from a placebo-controlled study.
배치운, Marks DM, Han C, Krulewicz S, Peindl K, Patkar AA, Masand PS
Primary Care Companion to the Journal of Clinical Psychiatry, 200806

204

Pravastatin as a therapeutic agent for atypical antipsychotic-induced metabolic syndrome in patients with schizophrenia.
배치운
CNS SPECTRUMS, 200805

205

Validation of the Patient Health Questionnaire-9 Korean version in the elderly population: the Ansan Geriatric Study
Han, CS, Jo, SA, Kwak, JH, Pae, CU, Steffens, D, Jo, I, Park, MH
COMPREHENSIVE PSYCHIATRY, 200803

206

Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder
Kim JJ (Kim, Jung-Jin), Mandelli L (Mandelli, Laura), Pae CU (Pae, Chi-Un), De Ronchi D (De Ronchi, Diana), Jun TY (Jun, Tae-Youn), Lee C (Lee, Chul), Paik IH (Paik, In-Ho), Patkar AA (Patkar, Ashwin A.), Steffens D (Steffens, David), Serretti A (Serretti, Alessand, Han C (Han, Changsu)
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY BIOLOGICAL PSYCHIATRY, 200802

207

Psychometric properties of the Korean version of the Short Post-Traumatic Stress Disorder Rating Interview (K-SPRINT)
Kim TS (Kim, Tae-Suk), Chung MY (Chung, Moon Yong), Kim W (Kim, Won), Koo YJ (Koo, Young Jin), Ryu SG (Ryu, Seong Gon), Kim EJ (Kim, Eui-Jung), Woo JM (Woo, Jong-Min), Kim TH (Kim, Tae-Hyung), Yang JC (Yang, Jong-Chul), Choi KS (Choi, Kyeong-Sook), Pae CU (Pae, Chi-Un), Seo HJ (Seo, Ho-Joon), Lim HK (Lim, Hyun-Kook), Chae JH (Chae, Jeong-Ho)
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 200802

208

Reply to Dr Ng's comments on A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression
Pae, CU, Masand, PS, Peindl, K, Hooper-Wood, C, Han, C, Mannelli, P, Ciccone, P, Patkar, AA
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 200802

209

Therapeutic possibility of Semax for depression
Pae, CU
CNS SPECTRUMS, 200801

210

Aripiprazole in the treatment of depressive and anxiety disorders: A review of current evidence
Pae CU (Pae, Chi-Un), Serretti A (Serretti, Alessand, Patkar AA (Patkar, Ashwin A.), Masand PS (Masand, Praksh S.)
CNS DRUGS, 200801